Cooper Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
MSV
AP
VWM
MPWT
GGS
SC
FFA
GI
LJHT
CPBTD
Cooper Financial Group's VRTX Position: Q3 2026 in Review
Cooper Financial Group increased its Vertex Pharmaceuticals (VRTX) stake by 0.74% in Q3 2026, buying an estimated $20K and bringing the position to 5,300 shares worth $2.77M. The position accounts for 0.22% of the portfolio, ranked #81.
Cooper Financial Group first reported a position in VRTX in Q4 2021 and has held it in 20 quarters since. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Cooper Financial Group held 5,300 shares of Vertex Pharmaceuticals worth $2.77M as of Q3 2026.
- Cooper Financial Group bought 39 Vertex Pharmaceuticals shares in Q3 2026, an estimated $20K.
- Vertex Pharmaceuticals made up 0.22% of Cooper Financial Group's portfolio in Q3 2026, its #81 holding.
- Cooper Financial Group first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
- 66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Cooper Financial Group's 13F filing for Q3 2026, filed 7 Oct 2026.